Health

IMI’s RADAR-CNS project is evaluating how wearable devices and smartphone technology could be used to monitor major depressive disorder, epilepsy, and multiple sclerosis. The project has now launched studies in all three disease areas; the results will ultimately make it easier to predict and hopefully prevent relapses, thereby dramatically improving patients’ quality of life.

An Antimicrobial Resistance (AMR) Accelerator Programme is part of new IMI Calls for proposals, along with topics on brain disorders, immune-mediated diseases clinical trial design, medicines safety, and blockchain technologies.

The Estonian genome project will provide personal feedback on the genetic information of a third of the population, laying the foundations for personalised medicine